Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Targeted drug therapy is the use of medicines that target or are directed at proteins on cancer cells that help them grow, spread, and live longer. Targeted drug therapy can be used to treat nasopharyngeal cancers by destroying cancer cells or slowing their growth. Many of these drugs can be taken as pills and their side effects are different from chemotherapy (sometimes less severe) .
Some targeted drugs, for example, monoclonal antibodies, work in more than one way to control cancer cells and may also be considered immunotherapy because they boost the immune system.
Epidermal growth factor receptor (EGFR) is a protein that helps cancer cells grow. One drug that targets EGFR can be used to treat some nasopharyngeal cancers.
Cetuximab (Erbitux) is a monoclonal antibody (a man-made version of an immune system protein). It targets EGFR which is a protein found on the surface of certain cancer cells that helps them grow and divide. Nasopharyngeal cancer (NPC) cells sometimes have higher than normal amounts of EGFR. By blocking EGFR, cetuximab can help slow or stop cancer cell growth.
The exact role of cetuximab in treating NPC is still being studied. It might be used along with chemo in cases where the cancer has spread, come back, or continued to grow after initial treatment with chemo.
Cetuximab is given by IV infusion, either once a week or every other week.
Common side effects include:
A rare but serious side effect of cetuximab is an allergic reaction during the first infusion, which could cause breathing problems and low blood pressure. You will be given medicine before treatment to help prevent this.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Ma BBY, Kam MKM, Leung SF, et al. A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Ann Oncol. 2012;23(5):1287-1292. doi:10.1093/annonc/mdr401.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers, Version 3.2021 – April 27, 2021. Accessed at www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf on May 20, 2021.
Last Revised: August 1, 2022
Donate now so we can continue to provide access to critical cancer information, resources, and support to improve lives of people with cancer and their families.